Details of the Drug Combinations

General Information of This Drug (ID: DMILWZR)

Drug Name
Rosiglitazone   DMILWZR
Indication
Disease Entry ICD 11 Status REF
Chronic kidney disease GB61 Terminated []

List of Combinatorial Drugs (CBD) Containing This Drug

10 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Casopitant + Rosiglitazone DC15KI5 Casopitant Nausea and Vomiting, Chemotherapy-Induced [1]
Glimepiride + Rosiglitazone DCNKMBL Glimepiride Diabetes [2]
Metformin + Rosiglitazone DCDFXP5 Metformin Advanced solid tumour; Diabetic complication [3]
Regorafenib + Rosiglitazone DCVH0P6 Regorafenib Neoplasms [4]
Repaglinide + Rosiglitazone DCSQ37Q Repaglinide Diabetes Mellitus, Type 2 [5]
Rosiglitazone + Cabozantinib DCTL892 Cabozantinib Papillary Thyroid Cancer [6]
Rosiglitazone + Exenatide DCVH3SK Exenatide Diabetes Mellitus, Type 2 [7]
Simvastatin + Rosiglitazone DCLMIB8 Simvastatin Pre-diabetes [8]
Simvastatin + Rosiglitazone DC7M4N9 Simvastatin Type-2 diabetes [9]
Vismodegib + Rosiglitazone DCRD9VE Vismodegib Solid Cancers [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 DrugCom(s)

References

1 ClinicalTrials.gov (NCT00511823) The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
2 ClinicalTrials.gov (NCT00343980) Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
3 FDA Drug Development and Drug Interactions
4 ClinicalTrials.gov (NCT01287598) BAY73-4506 Probe Substrate Study
5 ClinicalTrials.gov (NCT02475499) Incretin-based Drugs and Pancreatic Cancer
6 ClinicalTrials.gov (NCT01100619) A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
7 ClinicalTrials.gov (NCT00135330) An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
8 ClinicalTrials.gov (NCT00831129) A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs
9 Clinical pipeline report, company report or official report of GlaxoSmithKline.
10 ClinicalTrials.gov (NCT01209143) A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists